Cardiac Action Potential

Definition

The cardiac action potential is the electrical signal that initiates and coordinates the contraction of the heart muscle. It is the fundamental process that drives the rhythmic pumping of the heart, which is essential for circulating blood throughout the body.

5 Must Know Facts For Your Next Test

1. The cardiac action potential is initiated by the sinoatrial (SA) node, the heart's natural pacemaker, and propagates through the atria and ventricles.
2. Calcium ion influx through voltage-gated calcium channels is the primary driver of the plateau phase of the cardiac action potential, which sustains the contraction of the heart muscle.
3. Potassium ion efflux through voltage-gated potassium channels is the main mechanism responsible for the repolarization phase of the cardiac action potential.
4. The refractory period of the cardiac action potential ensures that the heart muscle can fully relax and refill with blood before the next contraction.
5. Disturbances in the cardiac action potential can lead to various cardiac arrhythmias, which are the focus of 17.1 Introduction to Dysrhythmias.

Review Questions

• Explain the role of the cardiac action potential in the rhythmic contraction of the heart.
  • The cardiac action potential is the electrical signal that originates in the sinoatrial (SA) node and propagates through the atria and ventricles, triggering the coordinated contraction of the heart muscle. The depolarization phase of the action potential causes calcium ions to enter the myocardial cells, initiating the contraction. The subsequent repolarization phase and refractory period allow the heart to relax and refill with blood before the next contraction, maintaining the heart's rhythmic pumping action.
• Describe how the cardiac action potential relates to the mechanism of action of Class IV antiarrhythmic drugs, such as calcium channel blockers.
  • Class IV antiarrhythmic drugs, like calcium channel blockers, work by interfering with the cardiac action potential. Specifically, they block the influx of calcium ions through voltage-gated calcium channels during the plateau phase of the action potential. This disrupts the normal depolarization and contraction of the myocardial cells, leading to a slowed heart rate and decreased contractility. By modulating the cardiac action potential, these drugs can help restore normal heart rhythm in patients with certain types of cardiac arrhythmias, as discussed in 17.5 Class IV: Calcium Channel Blockers.
• Analyze how disturbances in the cardiac action potential can contribute to the development of cardiac arrhythmias, and how unclassified antiarrhythmic drugs may target these abnormalities.
  • Disruptions in the normal sequence of the cardiac action potential, such as abnormal depolarization, prolonged repolarization, or altered refractory periods, can lead to the development of various cardiac arrhythmias. These disturbances may be caused by genetic factors, electrolyte imbalances, or the effects of certain medications. Unclassified antiarrhythmic drugs, discussed in 17.6 Unclassified Antidysrhythmics, work by targeting specific aspects of the cardiac action potential to restore normal heart rhythm. For example, some drugs may block sodium or potassium channels to shorten the action potential duration, while others may prolong the refractory period to prevent the propagation of abnormal electrical signals. Understanding the relationship between the cardiac action potential and arrhythmia pathogenesis is crucial for the effective management of these conditions.

Related terms

Depolarization: The rapid change in the electrical charge across the cell membrane, causing the cell to become more positive.

Repolarization: The process of restoring the resting potential of a cell after depolarization, making the cell's interior more negative.

Refractory Period: The period of time during which a cell is unable to be stimulated and generate a new action potential, even in the presence of a stimulus.